VITRIGEL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

VITRIGEL Trademark

Serial Number: 79274679 • Registration: 6138690

VITRIGEL is a trademark filed by National Agriculture and Food Research Organization on July 25, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

National Agriculture and Food Research Organization (2 trademarks)

3-1-1 Kannondai,

Entity Type: 99

Trademark Details

Filing Date

July 25, 2019

Registration Date

September 1, 2020

Published for Opposition

June 16, 2020

Goods & Services

Laboratory apparatus and instruments for the exchange of substances and heat; measuring or testing machines and instruments, namely, scales, measuring glassware, test tubes; incubators for laboratory use; cell culture apparatus for laboratory use, namely, cell culture dishes; cell culture apparatus for laboratory use, namely, tissue culture flasks; cell culture apparatus for research use, namely, bioreactor for cell culturing; furniture especially made and used for laboratories, namely, chambers for cell culture for laboratory use; bioreactors for cell culture; cell chips being bio-chips for research or scientific purposes

Pharmaceutical preparations for the treatment of wounds and cancer; chemical preparations for medical purposes, namely, treating ophthalmological, otolaryngological and dermatological diseases or disorders; chemical preparations for pharmaceutical purposes for eye irritation tests, corneal permeability tests, skin sensitization tests, vascular permeability tests, liver metabolism and excretion tests and intestine absorption tests; collagen for medical purposes; surgical mesh comprised primarily of living tissue; patches comprising living tissues for skin regeneration; patches comprising living tissues for reinforcement of living tissues; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; transplants, namely, implants comprising living tissues; human allograft tissue; drug delivery agents in the form of sheets, threads and hollow fibers that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; microcapsules for delivering drugs

Industrial chemicals; chemicals, namely, chemical preparations for scientific laboratory use other than for medical or veterinary purposes; cell culture media for scientific, laboratory and research use, other than for medical or veterinary purposes; microorganism cell culture media for laboratory, scientific and research use, other than for medical or veterinary purposes; cell culture media for scientific or research purposes; cell culture media for laboratory use

Medical apparatus and instruments for use in treating ophthalmological, otolaryngological and dermatological diseases and conditions; artificial skin for medical purposes; artificial skin for surgical purposes; prosthetics or fillings materials, namely, artificial materials for use in the replacement of bones, not for dental use; surgical mesh comprised primarily of artificial materials; suture materials; thread for medical purposes; sutures; hollow [ fibers ] * fiber membranes * for medical use; apparatus for drug delivery system, namely, syringes sold filled with living cells; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treatment of dermatological disease; prosthetic tissues for parietal use; prosthetic tissues for visceral use; prosthetic tissues for vascular use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 1, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 7, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2023 NREP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 3, 2023 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 29, 2022 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 28, 2022 COC.
LIMITATION OF GOODS RECEIVED FROM IB
Aug 7, 2022 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 18, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 18, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 1, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2020 CRFA
ASSIGNED TO LIE
May 13, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 7, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2019 REPR